Tobramycin solution
Tobramycin solution is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Tobramycin. Available dosage form: inhalant.
Drug details
- Generic Name
- Tobramycin solution
- Brand Names
- Tobramycin
- Application Number
- ANDA217344
- Sponsor
- Micro Labs Limited
- NDC Codes
- 1
- Dosage Forms
- INHALANT
- Routes
- RESPIRATORY (INHALATION)
- Active Ingredients
- TOBRAMYCIN
Indications and Usage
1 INDICATIONS AND USAGE Tobramycin inhalation solution is indicated for the management of cystic fibrosis in adults and pediatric patients 6 years of age and older with Pseudomonas aeruginosa . Safety and efficacy have not been demonstrated in patients under the age of 6 years, patients with forced expiratory volume in 1 second (FEV 1 ) <25% or >75% predicted, or patients colonized with Burkholderia cepacia [see Clinical Studies ( 14 )]. Tobramycin inhalation solution is an aminoglycoside antibacterial indicated for the management of cystic fibrosis in adults and pediatric patients 6 years of age and older with Pseudomonas aeruginosa . ( 1 ) Safety and efficacy have not been demonstrated in patients under the age of 6 years, patients with forced expiratory volume in 1 second (FEV1) <25% or >75% predicted, or patients colonized with Burkholderia cepacia. ( 1 )